Warburg Pincus to buy Bausch & Lomb

The global private equity firm has offered $4.5 billion for the eye health specialist, which recently was forced to recall products.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this